Recently, in order to minimize the symptoms, the treatment of TS is mainly focused on the recombinant human growth hormone (rhGF) therapy, which was reported to play important roles in carbohydrate accumulation, lipid decline and facilitating protein synthesis. This evidence concerns the gene GH1 and Timothy syndrome.